BEAM
Price
$25.10
Change
-$0.81 (-3.13%)
Updated
Jul 24 closing price
Capitalization
2.58B
17 days until earnings call
Intraday BUY SELL Signals
CRBU
Price
$1.57
Change
-$0.06 (-3.68%)
Updated
Jul 24 closing price
Capitalization
155.71M
18 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BEAM vs CRBU

BEAM vs CRBU Comparison Chart in %
View a ticker or compare two or three
VS
BEAM vs. CRBU commentary
Jul 25, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and CRBU is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 25, 2026
Stock price -- (BEAM: $25.10 vs. CRBU: $1.57)
Brand notoriety: BEAM and CRBU are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 52% vs. CRBU: 32%
Market capitalization -- BEAM: $2.58B vs. CRBU: $155.71M
BEAM [@Biotechnology] is valued at $2.58B. CRBU’s [@Biotechnology] market capitalization is $155.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileCRBU’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • CRBU’s FA Score: 1 green, 4 red.
According to our system of comparison, both BEAM and CRBU are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while CRBU’s TA Score has 3 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 5 bearish.
  • CRBU’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than CRBU.

Price Growth

BEAM (@Biotechnology) experienced а -8.83% price change this week, while CRBU (@Biotechnology) price change was -4.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.78%. For the same industry, the average monthly price growth was -3.76%, and the average quarterly price growth was +1901.89%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 11, 2026.

CRBU is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Biotechnology (-4.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.58B) has a higher market cap than CRBU($156M). CRBU YTD gains are higher at: -1.258 vs. BEAM (-9.452). CRBU has higher annual earnings (EBITDA): -116.43M vs. BEAM (-349.25M). BEAM has more cash in the bank: 1.21B vs. CRBU (118M). CRBU has less debt than BEAM: CRBU (26.9M) vs BEAM (251M). BEAM has higher revenues than CRBU: BEAM (164M) vs CRBU (11.2M).
BEAMCRBUBEAM / CRBU
Capitalization2.58B156M1,656%
EBITDA-349.25M-116.43M300%
Gain YTD-9.452-1.258751%
P/E RatioN/AN/A-
Revenue164M11.2M1,464%
Total Cash1.21B118M1,027%
Total Debt251M26.9M933%
FUNDAMENTALS RATINGS
BEAM: Fundamental Ratings
BEAM
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMCRBU
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
73%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
72%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 30 days ago
76%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signal:
Gain/Loss:
CRBU
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ETHD62.510.94
+1.53%
Proshares UltraShort Ether ETF
DFSU46.650.19
+0.40%
Dimensional US Sustainability Core 1 ETF
BGT10.79N/A
N/A
BlackRock Floating Rate Income Trust
DRAI33.18N/A
N/A
Draco Evolution AI ETF
FCTR38.55-0.68
-1.74%
First Trust Lunt US Factor Rotation ETF

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with EDIT. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
-3.68%
EDIT - CRBU
65%
Loosely correlated
-4.76%
CRSP - CRBU
55%
Loosely correlated
-2.08%
SANA - CRBU
53%
Loosely correlated
-0.93%
RXRX - CRBU
52%
Loosely correlated
-1.66%
BEAM - CRBU
51%
Loosely correlated
-3.13%
More